Neurogene Inc.
NGNE · NASDAQ · USD
$26.40
−0.10 −0.38%todayNot financial advice.
- Open
- 28.90
- Day range
- 26.01 - 29.63
- 52-week range
- 15.93 - 43.66
- Volume
- 465.9K
- Market cap
- 528.3M
- P/E ratio
- —
- EPS
- -5.5
- Dividend yield
- 0.00%
- Beta
- 1.71
Performance
W
−2.04%
1M
−30.60%
3M
−38.23%
6M
+22.85%
YTD
+27.78%
Y
−0.83%
5Y
−80.42%
All
−88.81%
In the news
Oct 8
J.P. Morgan Initiates Coverage on Neurogene With Overweight Rating
J.P. Morgan initiated coverage on Neurogene Inc. with an overweight rating, citing the growth potential of its Rett syndrome gene therapy program.
Analyst ratings
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-NGNE" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Neurogene Inc. (NGNE) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-NGNE">NGNE stock price</a> by FreeTheAI Stocks</p>